D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 32,791 287 World Ranking 4961 National Ranking 2817

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are Antigen, Immunology, Cancer, Immunohistochemistry and Melanoma. His Antigen study integrates concerns from other disciplines, such as Immunotherapy, Cancer/testis antigens, NY-ESO-1, Cytotoxic T cell and Antibody. His research integrates issues of Cancer research, Ovarian cancer and Multiple myeloma in his study of Cancer/testis antigens.

His studies deal with areas such as Clinical trial, Gene expression, Real-time polymerase chain reaction and Merkel cell carcinoma, Merkel cell polyomavirus as well as Cancer. His Immunohistochemistry study is focused on Pathology in general. His work deals with themes such as Gene product, Lung cancer, Melanocyte differentiation and Metastasis, which intersect with Melanoma.

His most cited work include:

  • Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer (1739 citations)
  • Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma (1374 citations)
  • Cancer/testis antigens, gametogenesis and cancer. (1194 citations)

What are the main themes of his work throughout his whole career to date?

Pathology, Immunohistochemistry, Antigen, Cancer research and Cancer are his primary areas of study. As a part of the same scientific family, Achim A. Jungbluth mostly works in the field of Immunohistochemistry, focusing on Melanoma and, on occasion, Arginine deiminase. His Antigen study is concerned with Immunology in general.

His Cancer research research includes themes of Cell and Gene. His Cancer research is multidisciplinary, incorporating elements of Gene expression and Oncology. The study incorporates disciplines such as Adjuvant and Colorectal cancer in addition to Antibody.

He most often published in these fields:

  • Pathology (37.83%)
  • Immunohistochemistry (37.24%)
  • Antigen (36.66%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (25.22%)
  • Immunohistochemistry (37.24%)
  • Pathology (37.83%)

In recent papers he was focusing on the following fields of study:

Achim A. Jungbluth mainly focuses on Cancer research, Immunohistochemistry, Pathology, Immunotherapy and Cancer. His Cancer research research integrates issues from Exome sequencing, Fusion gene, Gene and Transposon mutagenesis. His Immunohistochemistry study incorporates themes from Staining, PRAME, Molecular biology, Melanoma and Antibody.

His PRAME study combines topics in areas such as Cancer/testis antigens and Antigen. His Immunotherapy research incorporates themes from Blockade and Tissue microarray. His research in Cancer intersects with topics in Oncology and Somatic cell.

Between 2016 and 2021, his most popular works were:

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. (429 citations)
  • Integrative Molecular Characterization of Malignant Pleural Mesothelioma (180 citations)
  • Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. (176 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Achim A. Jungbluth focuses on Immunohistochemistry, Pathology, Cancer research, Immunotherapy and Gene. He combines subjects such as Pathogenesis, Staining, Nevus, Melanoma and Lung with his study of Immunohistochemistry. Achim A. Jungbluth has included themes like Gene rearrangement, Phenotype, Chromogranin A, Gene duplication and Synaptophysin in his Cancer research study.

His Immunotherapy study is related to the wider topic of Cancer. His Cancer study is associated with Internal medicine. His research in PD-L1 tackles topics such as Concordance which are related to areas like Antibody.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

Eiichi Sato;Sara H. Olson;Jiyoung Ahn;Brian Bundy.
Proceedings of the National Academy of Sciences of the United States of America (2005)

2247 Citations

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow;Margaret K. Callahan;Margaret K. Callahan;Christopher A. Barker;Christopher A. Barker;Yoshiya Yamada;Yoshiya Yamada.
The New England Journal of Medicine (2012)

1687 Citations

Cancer/testis antigens, gametogenesis and cancer.

Andrew J. G. Simpson;Otavia L. Caballero;Achim Jungbluth;Yao-Tseng Chen.
Nature Reviews Cancer (2005)

1586 Citations

Characterization of tumor necrosis factor-deficient mice

Michael W. Marino;Ashley Dunn;Dianne Grail;Melissa Inglese.
Proceedings of the National Academy of Sciences of the United States of America (1997)

1122 Citations

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.

Matthew J. Scanlan.;Ali O. Gure.;Achim A. Jungbluth.;Lloyd J. Old..
Immunological Reviews (2002)

1037 Citations

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

Naomi N. Hunder;Herschel Wallen;Jianhong Cao;Deborah W. Hendricks.
The New England Journal of Medicine (2008)

969 Citations

Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues

Achim A. Jungbluth;Yao-Tseng Chen;Elisabeth Stockert;Klaus J. Busam.
International Journal of Cancer (2001)

643 Citations

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.

Ian D. Davis;Ian D. Davis;Weisan Chen;Heather Jackson;Phillip Parente;Phillip Parente.
Proceedings of the National Academy of Sciences of the United States of America (2004)

506 Citations

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann.
Cancer Discovery (2018)

496 Citations

Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

Elke Jäger;Yasuhiro Nagata;Sacha Gnjatic;Hisashi Wada.
Proceedings of the National Academy of Sciences of the United States of America (2000)

492 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Achim A. Jungbluth

Lloyd J. Old

Lloyd J. Old

Ludwig Cancer Research

Publications: 162

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 126

Andrew M. Scott

Andrew M. Scott

La Trobe University

Publications: 111

Sacha Gnjatic

Sacha Gnjatic

Icahn School of Medicine at Mount Sinai

Publications: 92

Kunle Odunsi

Kunle Odunsi

Roswell Park Cancer Institute

Publications: 88

George Coukos

George Coukos

University of Lausanne

Publications: 77

Audrey Goddard

Audrey Goddard

Genentech

Publications: 76

Jonathan Cebon

Jonathan Cebon

La Trobe University

Publications: 73

Paul J. Godowski

Paul J. Godowski

Genentech

Publications: 71

Alexander Knuth

Alexander Knuth

University of Zurich

Publications: 69

Gerd Ritter

Gerd Ritter

Memorial Sloan Kettering Cancer Center

Publications: 66

Sergei A. Nedospasov

Sergei A. Nedospasov

Engelhardt Institute of Molecular Biology

Publications: 66

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 63

Yao-Tseng Chen

Yao-Tseng Chen

Cornell University

Publications: 59

Silvia C. Formenti

Silvia C. Formenti

Cornell University

Publications: 55

Cristina R. Antonescu

Cristina R. Antonescu

Memorial Sloan Kettering Cancer Center

Publications: 55

Something went wrong. Please try again later.